Q10 improves survival odds in heart failure | Meta study
As cardiologists are saving more and more people from previously fatal cardiovascular incidents, the number of people with heart failure is steadily increasing. For this growing group of patients, supplementation with Q10 may be of interest. Li Lei and Yan Liu, two cardiologists from Yulin Traditional Chinese Medicine Hospital, conclude this in a meta-study published in 2017 in BMC Cardiovascular Disorders.Study
The researchers traced 14 trials involving a total of 2,149 patients with heart failure. The patients in the experimental group received Q10 at doses of 100-800 milligrams per day.
The researchers aggregated the trials' results and analyzed them again.Results
There was a trend that the heart of the subjects in the Q10 groups could pump more blood than that of the subjects in the placebo groups, but this trend was not significant.
The figures below have been reduced. Click on it for a readable version.
[FONT="]
[/FONT]
[FONT="]
[/FONT]
Finally, Q10 improved the subjects' physical endurance. The supplement made them fitter.
[FONT="]
[/FONT]
[FONT="]
[/FONT]
Conclusion
"Patients with heart failure who used coenzyme Q10 had lower mortality and a higher exercise capacity improvement than the placebo-treated patients with heart failure", write the researchers.
Source:
BMC Cardiovasc Disord. 2017 Jul 24;17(1):196.
|
The researchers traced 14 trials involving a total of 2,149 patients with heart failure. The patients in the experimental group received Q10 at doses of 100-800 milligrams per day.
There was a trend that the heart of the subjects in the Q10 groups could pump more blood than that of the subjects in the placebo groups, but this trend was not significant.
The figures below have been reduced. Click on it for a readable version.
[FONT="]
[/FONT]
[FONT="]
[/FONT]
Finally, Q10 improved the subjects' physical endurance. The supplement made them fitter.
[FONT="]
[/FONT]
[FONT="]
[/FONT]
Conclusion
"Patients with heart failure who used coenzyme Q10 had lower mortality and a higher exercise capacity improvement than the placebo-treated patients with heart failure", write the researchers.
Source:
BMC Cardiovasc Disord. 2017 Jul 24;17(1):196.